Bioverse Peptide Facebook ad: “Semaglutide: 1 jalur.”

Ran for 78 days, from May 23 to August 9, 2026, the last day Crush saw it.

Run by Bioverse Peptide on Facebook. Crush is not the advertiser and does not verify its claims. See this ad in Meta's Ad Library(opens in a new tab)

Want an ad like this for your product?

Crush makes new ad images for your product from this ad: your logo, your product photo, your offer.

Trials from $19.95 USD, then $79.95 USD a month. Cancel anytime.

About this ad

Meta Ad Library ID: 820288834208055
Platforms: Facebook and Instagram
Relaunches: 1
Niche: Supplements & Wellness

How we count

Ad text

Semaglutide: 1 jalur. Tirzepatide: 2 jalur. Retatrutide: 3 jalur. GLP-1. GIP. Glucagon. Tiga reseptor yang mengatur metabolisme lo, diaktifkan sekaligus oleh satu compound. Uji 48 minggu, dosis tertinggi (Jastreboff et al., NEJM 2023). Pola yang muncul: makin banyak jalur, makin besar respons. Triple pathway tampil paling kuat di kelas compound ini. Data ini dari Phase 2. Phase 3 udah mulai readout dan hasilnya konsisten. Bioverse tetap nunjukin datanya, bukan janji-nya. Swipe buat ngerti mekanismenya. Komen RETA kalau lo udah jaga makan dan latihan tapi progresnya masih mentok. Gua kirim ringkasan mekanismenya di DM. Cek link di bio kalau mau versi lengkap. #retatrutide #metabolisme #riset #tripleagonist #bioversepeptide

Where the ad sends people

instagram.com

Bioverse Peptide

View instagram profile: instagram.com